≡ Menu

Alzheimer’s may be effected by hypertension

Risk associated with high blood pressure, or hypertension, is well known. Researchers Cyrus Raji, M.D., PhD., and Oscar Lopez, M.D., of the University of Pittsburgh, have added one new danger—blood flow to the brain. Using magnetic resonance imaging (MRI) to measure blood flow to the brain the researchers studied a group of 88 older patients. Within the… Read More

World Fibromyalgia Day – May 12, 2008

Heanne Hambleton lives in England and has found what so many other Fibromyalgia patients have experienced world wide--that it is difficult for friends, family, and neighbors to understand and appreciate the pain and suffering. It is sometimes difficult to comprehend how someone can look so normal, but be in constant pain. In a recent post… Read More

Parkinson’s treated with therapeutic cloning

Parkinson's disease is thought to be caused by missing dopamine neurons. Stem cell research has sought a way to restore the missing dopamine neurons, but often the immune system rejects the transplanted cells. Lorenz Studer, MD, Head of Stem Cell and Tumor Biology Laboratory, Sloan-Kettering Cancer Center, feels that their latest study reduces the chances that… Read More

Chronic pain helped by focusing on the moment

It may seem contrary to focus on your body when you feel pain. After all isn't it natural to want to block it so you do not think about it? Psychologist Dr. David Kannerstein's approach is to have the patient focus on breathing (unless of course breathing is the cause of the pain), to be… Read More

Painkiller abuse less than 3% in chronic pain patients

Strict government oversite of opioid medications force physicians to balance the needs of their patients with demands from the government for better control of opioid medications. Fifty years ago cancer patients were denied opioids for their pain because of possible addiction. Srinivasa Raja, MD, professor of anesthesiology, Johns Hopkins University Medical School, reports that less than… Read More

Drug companies declare war on “Sicko”

Release of Michael Moore's, Sicko is a week away and drug companies prepare to counter attack claims made in the film. They feel the American health care system has been unjustly characterized as 'sick.' One issue they have with the film is that Moore doesn't pin down what works and what needs to be improved… Read More

Disabled achievers focus of film festival

The International Disability Film Festivalheld its 27th annual event in Berkeley. Thirteen award winners were chosen from the 45 entries submitted from 10 countries… Read More

Baylor study finds antidepressants not for bipolar treatment

Baylor College of Medicine's associate professor of psychiatry and behavioral sciences, Laura Marangell, M.D., challenges the use of antidepressants with mood stabilizers. She found that bipolar disorder patients given antidepressants are not relieved from their depression any better than when they are given a placebo. Often bipolar disorder's mood swings between depression and mania are… Read More

University of Missouri awarded NIH grant for Alzheimer’s research

University of Missouri, Columbia, received a $6 million National Institutes of Health (NIH) grant to continue research on ways to prevent and cure Alzheimer's disease. This grant dove-tails on the previous $5 million, 5-year, grant provided by the NIH. The first NIH grant helped researchers to recognize two major abnormalities of Alzheimer's patients. First, Alzheimer… Read More

FDA places gene therapy clinical trial on hold after woman’s death

Sadly, a Seattle patient, who was part of a gene therapy clinical trial for inflammatory arthritis, died unexpectedly. As a result the FDA called a halt to the clinical trial. The company conducting the clinical trial, Targeted Genetics, notified the FDA when the patient died. The clinical trial will remain on hold until the cause… Read More

Dementia risk reduced by long-term use of beta carotene

Brigham and Women's Hospital has released the results of a long-term study involving the effects of beta carotene supplement on dementia. Beta carotene is thought to help fight cellular damage from oxidative stress, which is a major factor in cognitive decline. Although, there was evidence that an antioxidant, like beta carotene, might help preserve cognition previous studies… Read More

Disease management care has benefits at a cost

In 2005 health insurance plans and employers spent $1.2 billion on disease management programs. Management programs have become a key point in the national health care reform debate as policymakers search for a way to improve health care quality and access, while at the same time controlling cost. Disease management has become viewed as the silver… Read More

Terms of Use
Privacy Policy
FTC Statement
Medical Disclaimer
Affiliate Disclosure